Target To Treatment (Ttt) Consulting Limited
- Company number
- 10023067
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 24 Feb 2016
- Nature of business
- Research and experimental development on biotechnology
Registered office
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Dr Pauline Teresa Lukey | Voting Rights 75 To 100 Percent | 6 Apr 2016 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 28 Feb 2025 | £32,809 | £22,032 | 4 |
| 29 Feb 2024 | £58,037 | £45,996 | 3 |
| 28 Feb 2023 | £40,519 | £37,670 | 3 |
| 28 Feb 2022 | £74,899 | £69,618 | 3 |
| 28 Feb 2021 | £67,124 | £57,320 | 3 |
| 29 Feb 2020 | £54,703 | £43,538 | 2 |
| 28 Feb 2019 | £78,215 | £82,471 | 2 |
| 28 Feb 2018 | £58,417 | £55,411 | 2 |
| 28 Feb 2017 | £29,116 | £39,165 | 2 |
Connections
Companies at the same address
- Applied Exomics Ltd (08251827)
- Artemida Pharma Limited (09004411)
- Autifony Alpha Limited (11924528)
- Autifony Therapeutics Limited (07543962)
- Awridian Ltd (07798594)
- Bioa3 Ltd (16700091)
- Biores Ltd (16349656)
- Cerebro Cmc Limited (10876137)
- Hubro Bioscience Ltd (16824289)
- Isoform Oncology Ltd (16014187)